Bay Rivers Group Milestone Pharmaceuticals Inc. Transaction History
Bay Rivers Group
- $209 Million
- Q2 2025
A detailed history of Bay Rivers Group transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Bay Rivers Group holds 14,321 shares of MIST stock, worth $21,338. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,321Holding current value
$21,338% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
52Shares Held
16.8MCall Options Held
341KPut Options Held
70.3K-
Black Rock Inc. New York, NY4.97MShares$7.41 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$3.73 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.16 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.13 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.69 Million0.74% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $44.7M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...